<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04242355</url>
  </required_header>
  <id_info>
    <org_study_id>2000021846</org_study_id>
    <nct_id>NCT04242355</nct_id>
  </id_info>
  <brief_title>Transcranial Magnetic Stimulation on Neural and Behavioral Facets of Social Cognition in Autism Spectrum Disorder</brief_title>
  <acronym>TMSinASD</acronym>
  <official_title>Effects of Repetitive Transcranial Magnetic Stimulation on Neural and Behavioral Facets of Social Cognition in Autism Spectrum Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the effects of repetitive Transcranial Magnetic Stimulation (rTMS)&#xD;
      on neural and behavioral facets of social cognition in Autism Spectrum Disorder (ASD).&#xD;
      Participant visits will include a baseline assessment of neuropsychological, cognitive and&#xD;
      behavioral function, and an EEG (electroencephalogram) and eye-tracking session to measure&#xD;
      neural and visual attentional social response before and after administration of TMS.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Broad ranging social cognition difficulties are hallmark areas of impairment in autism&#xD;
      spectrum disorder (ASD), and they are subserved by specific neural systems underpinning&#xD;
      social perception and processing that are recognized to be atypical in ASD. Considering the&#xD;
      neurodevelopmental nature of the disorder, and the recent findings regarding aberrant&#xD;
      neuroplasticity in ASD, repetitive transcranial magnetic stimulation (rTMS) holds promise to&#xD;
      directly modulate brain activity in these systems. The objective of this research proposal is&#xD;
      to utilize a multimodal approach to provide a proof-of-concept for the ability of rTMS to (a)&#xD;
      influence functioning in the brain systems involved in social ASD symptomatology and (b)&#xD;
      modify associated social cognitive behaviors in adults with ASD. Toward achieving this&#xD;
      objective, we propose to assess critical aspects of social cognition using the&#xD;
      electroencephalogram (EEG), event-related potentials (ERPS), eye-tracking (ET), and&#xD;
      behavioral tasks prior to and following a single rTMS session to provide preliminary insight&#xD;
      into the potential of rTMS as a tool to modify social brain function in cognitively able&#xD;
      adults with ASD.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Anticipated">July 2025</completion_date>
  <primary_completion_date type="Anticipated">July 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>right lateralized N170 latency to upright faces</measure>
    <time_frame>Measures will be recorded for the duration of their visit, an expected average of 4-5 hrs.</time_frame>
    <description>EEG brain response to faces as measured by the N170 component in milliseconds</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>proportion of visual attention to the eye region of the face</measure>
    <time_frame>Measures will be recorded for the duration of their visit, an expected average of 4-5 hrs.</time_frame>
    <description>visual attention to the eye region of the face as measured by eye tracking in seconds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Benton Face Recognition Task</measure>
    <time_frame>Measures will be recorded for the duration of their visit, an expected average of 4-5hrs</time_frame>
    <description>The total Benton score will be used to assess the ability to recognize and discriminate among faces</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Autism Spectrum Disorder</condition>
  <arm_group>
    <arm_group_label>Transcranial Magnetic Stimulation - real</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive active TMS during their study visit</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transcranial Magnetic Stimulation - sham</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will receive sham stimulation during their study visit simulating TMS</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Transcranial Magnetic Stimulation (TMS)</intervention_name>
    <description>Subjects will receive both active and sham TMS in a randomized crossover assignment involving two study sessions</description>
    <arm_group_label>Transcranial Magnetic Stimulation - real</arm_group_label>
    <arm_group_label>Transcranial Magnetic Stimulation - sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  individuals between the ages of 18 and 40 years old with typical development or with a&#xD;
             diagnosis of autism spectrum disorder.&#xD;
&#xD;
          -  able to participate in an EEG and eye-tracking experiment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participants reporting significant head trauma or serious brain illness&#xD;
&#xD;
          -  Participants with major psychiatric illness that would preclude completion of study&#xD;
             measures.&#xD;
&#xD;
          -  Participants with a history of serious medical illness, stroke, seizures, epileptiform&#xD;
             EEG abnormalities, or family history of seizures.&#xD;
&#xD;
          -  Participants taking prescription medications that may affect cognitive processes under&#xD;
             study.&#xD;
&#xD;
          -  Participants who have taken alcohol or recreational drugs within the preceding 24&#xD;
             hours.&#xD;
&#xD;
          -  Females of known/suspected pregnancy or who test positive on a pregnancy test.&#xD;
&#xD;
          -  Participants with a history of metalworking or injury by shrapnel or metallic objects&#xD;
             are also exclude&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009 Dec;120(12):2008-2039. doi: 10.1016/j.clinph.2009.08.016. Epub 2009 Oct 14. Review.</citation>
    <PMID>19833552</PMID>
  </reference>
  <reference>
    <citation>Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron. 2005 Jan 20;45(2):201-6.</citation>
    <PMID>15664172</PMID>
  </reference>
  <reference>
    <citation>Allison T, Puce A, McCarthy G. Social perception from visual cues: role of the STS region. Trends Cogn Sci. 2000 Jul;4(7):267-278.</citation>
    <PMID>10859571</PMID>
  </reference>
  <reference>
    <citation>McPartland J, Dawson G, Webb SJ, Panagiotides H, Carver LJ. Event-related brain potentials reveal anomalies in temporal processing of faces in autism spectrum disorder. J Child Psychol Psychiatry. 2004 Oct;45(7):1235-45.</citation>
    <PMID>15335344</PMID>
  </reference>
  <reference>
    <citation>Dawson G, Toth K, Abbott R, Osterling J, Munson J, Estes A, Liaw J. Early social attention impairments in autism: social orienting, joint attention, and attention to distress. Dev Psychol. 2004 Mar;40(2):271-83.</citation>
    <PMID>14979766</PMID>
  </reference>
  <reference>
    <citation>Oberman LM, Rotenberg A, Pascual-Leone A. Use of transcranial magnetic stimulation in autism spectrum disorders. J Autism Dev Disord. 2015 Feb;45(2):524-36. doi: 10.1007/s10803-013-1960-2. Review.</citation>
    <PMID>24127165</PMID>
  </reference>
  <reference>
    <citation>Abujadi C, Croarkin PE, Bellini BB, Brentani H, Marcolin MA. Intermittent theta-burst transcranial magnetic stimulation for autism spectrum disorder: an open-label pilot study. Braz J Psychiatry. 2018 Jul-Sep;40(3):309-311. doi: 10.1590/1516-4446-2017-2279. Epub 2017 Dec 11.</citation>
    <PMID>29236921</PMID>
  </reference>
  <reference>
    <citation>Ni HC, Hung J, Wu CT, Wu YY, Chang CJ, Chen RS, Huang YZ. The Impact of Single Session Intermittent Theta-Burst Stimulation over the Dorsolateral Prefrontal Cortex and Posterior Superior Temporal Sulcus on Adults with Autism Spectrum Disorder. Front Neurosci. 2017 May 9;11:255. doi: 10.3389/fnins.2017.00255. eCollection 2017.</citation>
    <PMID>28536500</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 15, 2020</study_first_submitted>
  <study_first_submitted_qc>January 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2020</study_first_posted>
  <last_update_submitted>April 16, 2021</last_update_submitted>
  <last_update_submitted_qc>April 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yale University</investigator_affiliation>
    <investigator_full_name>James C. McPartland</investigator_full_name>
    <investigator_title>Associate Professor of Child Psychiatry and Psychology</investigator_title>
  </responsible_party>
  <keyword>TMS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

